Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2 USD | -33.33% | -.--% | -66.67% |
2023 | Tengjun Biotechnology Corp. Announces Chief Executive Officer Changes | CI |
2023 | Tengjun Biotechnology Corp. Announces Chief Financial Officer Changes | CI |
Sales 2021 | - | Sales 2022 | 150.14 205.45 | Capitalization | 385M 527M |
---|---|---|---|---|---|
Net income 2021 | - 0 | Net income 2022 | 11M 15.05M | EV / Sales 2021 | - |
Net cash position 2021 | 286K 391K | Net cash position 2022 | 2.83M 3.87M | EV / Sales 2022 | 2,547,052 x |
P/E ratio 2021 |
-81.4
x | P/E ratio 2022 |
28.3
x | Employees | 27 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 54.26% |
1 day | -33.33% | ||
6 months | -76.47% | ||
Current year | -66.67% |
Managers | Title | Age | Since |
---|---|---|---|
Qing Bao Wang
CEO | Chief Executive Officer | 50 | 11-15 |
Caihong Qu
SEC | Corporate Secretary | 49 | 23-08-09 |
Members of the board | Title | Age | Since |
---|---|---|---|
Suzhen Zhang
BRD | Director/Board Member | 70 | 19-12-09 |
Huaping Lu
BRD | Director/Board Member | 57 | 19-12-09 |
Caihong Qu
SEC | Corporate Secretary | 49 | 23-08-09 |
1st Jan change | Capi. | |
---|---|---|
-66.67% | 201M | |
+27.73% | 66.05B | |
+44.10% | 36.81B | |
+29.14% | 9.19B | |
-0.53% | 6.67B | |
+11.11% | 6.49B | |
+3.67% | 5.13B | |
+4.41% | 4.59B | |
-11.75% | 3.18B | |
+4.89% | 2.53B |
- Stock Market
- Equities
- TJBH Stock